Written by
Imogen Fitt
This is the first iteration of our Market Report on the global market for Oncology IT, including Oncology Information Systems, Oncology Pathway Software, Tumour Board Software, Oncology AI for Autocontouring, published in June 2021.
Key issues addressed in the report include:
- How large is the global market for oncology informatics in terms of revenue and how will this change over the next five years?
- How does the market break out in terms of central oncology information systems (OIS), best of breed analytics, clinical decision support/pathway tools, radiation therapy solutions, tumour board platforms and integrated EMR modules?
- Will OIS and central oncology data management be cannibalised by EMR, or remain a best-of-breed market?
- What role will AI play in shaping new product markets?
- How will clinical trial management and CRO platforms integrate with Oncology IT?
- Who are the leading vendors and what is needed to stay competitive?
This report explores the post-diagnostic oncology IT market. Questions explored include:
- How quickly is the convergence of EMR/OIS systems is occurring in different markets?
- What is the opportunity for tumour board management software vendors?
- How will the growth of AI/analytics-based capabilities unfold in the oncology department? What is the role of oncology pathway software in clinical decision making?
- This report will enable users to evaluate and quantify the market opportunity for new and emerging segments, as well as measure the transition between Best-of-Breed and EHR OIS software, ultimately providing support for product and marketing roadmapping across Oncology IT.